CONGRESS|#EHA2021| Paula Restrepo, reported data for prognostic biomarker signature for selinexor, botezomib & dexamethasone response in MM pts. STORM & independent cohorts have validated this data. #mmsm, #myeloma,@TischCancer pic.twitter.com/KDRtZXzXBw
— Multiple Myeloma Hub (@MM_Hub) June 13, 2021